INDO US BIOTECH LTD Fair Value
INDOUS · Fast Moving Consumer Goods · Current price ₹78.99
| Method | Fair value | Status |
|---|---|---|
| Residual income | ₹47 | 14% ROE fading to 13% over ~3 yrs, on ₹46 book |
| Relative P/E | ₹304 | EPS × 46.5 peer-median P/E |
| Graham floor | ₹83 | Conservative floor: √(22.5 × EPS × book value/share) |
| Analyst target | — | No analyst coverage |
Is INDO US BIOTECH LTD undervalued?
DocStoX estimates the fair value of INDO US BIOTECH LTD at ₹125 per share, versus the current market price of ₹79. That puts the stock about +58.1% below our fair-value estimate, which we read as "Strong Buy". Our confidence in this estimate is low.
How this fair value is calculated
This estimate blends 3 independent methods: Residual income (₹47), Relative P/E (₹304), Graham floor (₹83). We weight each by its reliability and skip any method whose inputs look untrustworthy — "no DCF beats a wrong DCF". This is the same deterministic engine that powers DocStoX stock pages; there is no guesswork or AI-generated number here.
Bear, base and bull scenarios
Our scenarios span ₹47 (bear) to ₹125 (base) to ₹304 (bull). A margin of safety means buying meaningfully below the base case — the wider the gap, the more room for error in the assumptions.
More on INDO US BIOTECH LTD
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.